PRESS RELEASE published on 03/17/2026 at 19:00, 1 month 22 days ago Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
BRIEF published on 12/16/2025 at 09:58, 4 months 24 days ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 4 months 24 days ago Virbac acquiert Thyronorm pour le traitement de l'hyperthyroïdie féline Acquisition Santé Animale VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 4 months 24 days ago Virbac acquiert Thyronorm pour lutter contre l'hyperthyroïdie féline Santé Animale Médecine Vétérinaire VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 4 months 24 days ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 4 months 24 days ago VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Virbac acquiert Thyronorm pour traiter l'hyperthyroïdie féline, améliorant la qualité de vie des chats âgés. L'acquisition renforce le portefeuille produits de Virbac Acquisition VIRBAC Hyperthyroïdie Féline Thyronorm Chats Âgés
PRESS RELEASE published on 12/16/2025 at 09:53, 4 months 24 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
BRIEF published on 11/07/2025 at 15:44, 6 months 2 days ago Virbac : Mise à jour sur les actions et droits de vote Euronext Paris Droits De Vote Actions Transparence VIRBAC
BRIEF published on 11/07/2025 at 15:44, 6 months 2 days ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
PRESS RELEASE published on 11/07/2025 at 15:39, 6 months 2 days ago Virbac : Déclaration d'actions et de droits de vote 10/2025 Déclaration du nombre total d’actions et de droits de vote pour VIRBAC sur Euronext Paris. Total brut de droits de vote : 12 704 809, total net : 12 691 973 Euronext Paris Droits De Vote Santé Animale VIRBAC Total Actions
Published on 05/09/2026 at 01:30, 15 hours 57 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 17 hours 27 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 20 hours 49 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 22 hours 14 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 22 hours 24 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 22 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 22 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 22 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 22 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 22 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
